Published in J Reticuloendothel Soc on September 01, 1980
The suppressive effect of immunization on the proliferative responses of rat T cells in vitro. J Immunol (1975) 1.57
Separation of T cell subpopulations capable of DNA synthesis, lymphotoxin release, and regulation of antigen and phytohemagglutinin responses on the basis of density and adherence properties. Proc Natl Acad Sci U S A (1975) 1.07
The suppressive effect of immunization on the proliferative responses of rat T cells in vitro. II. Abrogation of antigen-induced suppression by selective cytotoxic agents. J Immunol (1976) 0.96
Murine lymphocyte comitogenesis by phorbol esters, and its inhibition by retinoic acid and inhibitors of polyamine biosynthesis. Toxicol Appl Pharmacol (1981) 0.91
In vitro responses of rat lymphocytes following adult thymectomy. III. Prevention by thymic factor of increased suppressor activity in the spleen. Cell Immunol (1976) 0.88
A Southeastern Cancer Study Group phase I/II trial with vaccinia melanoma oncolysates. Cancer (1986) 0.85
Positive relationship of clinical and serologic responses to vaccinia melanoma oncolysate. Arch Surg (1987) 0.84
Carrageenan-induced suppression of T lymphocyte proliferation in the rat: in vitro production of a suppressor factor by peritoneal macrophages. J Reticuloendothel Soc (1980) 0.83
Immunoregulation of Heymann's nephritis. I. Induction of suppressor cells. J Immunol (1979) 0.83
Active specific immunotherapy with vaccinia colon oncolysate enhances the immunomodulatory and antitumor effects of interleukin-2 and interferon alpha in a murine hepatic metastasis model. Cancer Immunol Immunother (1990) 0.82
Kinetic study of T lymphocytes after sensitization against soluble antigen. III. Potentiation and suppression of the PHA response by antigen-activated lymphocytes of low density. J Exp Med (1975) 0.82
Cellular immunosenescence in F344 rats: decreased natural killer (NK) cell activity involves changes in regulatory interactions between NK cells, interferon, prostaglandin and macrophages. Mech Ageing Dev (1984) 0.81
Suppression of rat T cell proliferation by Corynebacterium parvum: T cell requirement for induction. J Reticuloendothel Soc (1978) 0.80
Effects of tumor-promoting agents on cells of the murine immune system: inhibition of antibody synthesis and of macrophage-mediated tumor cell cytotoxicity. Carcinog Compr Surv (1982) 0.79
3-deazaadenosine, a transmethylase inhibitor, suppresses the effect of lipopolysaccharide on release of prostacyclin and thromboxane. J Pharm Pharmacol (1981) 0.79
Vaccinia virus-infected C-C36 colon tumor cell lysates stimulate cellular responses in vitro and protect syngeneic Balb/c mice from tumor cell challenge. J Surg Oncol (1989) 0.76
Leukotriene C stimulates prostaglandin release from rat peritoneal macrophages. Biochem Biophys Res Commun (1981) 0.75
Vaccinia virus oncolysates in the treatment of malignant melanoma. Cancer Treat Res (1988) 0.75
Cellular immunosenescence in F344 rats: decline in responsiveness to phytohemagglutinin involves changes in both T cells and macrophages. Mech Ageing Dev (1983) 0.75
A search for markers of rabbit lymphoid cells; alloantigens characterized by antisera to rabbit thymus. Int Arch Allergy Appl Immunol (1974) 0.75
Serological evaluation of melanoma patients in a phase I/II trial of vaccinia melanoma oncolysate (VMO) immunotherapy. Cancer Detect Prev Suppl (1987) 0.75
Phenotypic analysis of a human hematopoietic cell line with lymphoid and myeloid features using simultaneous multicolor flow cytometry. Transplant Proc (1997) 0.75
Melanoma patient antibody responses to melanoma tumor-associated antigens defined by murine monoclonal antibodies. J Biol Response Mod (1989) 0.75
Autoantibodies to vitreous body in sheep. Vox Sang (1970) 0.75
Immunomodulatory activities of human leukocyte interferon in advanced cancer patients. J Biol Response Mod (1983) 0.75
The effect of treatment with Corynebacterium parvum on the development and growth of experimental hematogenic metastases of schwannoma in the rat. Acta Neuropathol (1985) 0.75
Reflections on my mentor, Felix Milgrom. Transplant Proc (1999) 0.75
Monoclonal antibodies to the cell surface of a unique human lymphoid/myeloid cell line detect epitopes absent from peripheral blood mononuclear cells. Transplant Proc (1997) 0.75
Inhibition of macrophage-induced tumor cell cytostasis and cytolysis by tumor-promoting phorbol diesters. Toxicology (1981) 0.75
Studies on allotypes in sheep. Int Arch Allergy Appl Immunol (1972) 0.75
Vaccinia colon oncolysate immunotherapy for murine hepatic metastases can be modulated with low-dose interleukin-2. Third place winner: Conrad Jobst Award. Am Surg (1988) 0.75
Treatment of murine hepatic metastases with vaccinia colon oncolysates and IL-2. J Surg Res (1988) 0.75
Parallel orders of reactivity in murine cells of mezerein and phorbol esters toward the mixed-lymphocyte response and promotion of tumorigenesis. Toxicol Appl Pharmacol (1981) 0.75